KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Assets Average (2016 - 2025)

Historic Assets Average for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to $38.6 million.

  • TherapeuticsMD's Assets Average fell 314.14% to $38.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.6 million, marking a year-over-year decrease of 314.14%. This contributed to the annual value of $41.1 million for FY2024, which is 3860.14% down from last year.
  • TherapeuticsMD's Assets Average amounted to $38.6 million in Q3 2025, which was down 314.14% from $38.4 million recorded in Q2 2025.
  • Over the past 5 years, TherapeuticsMD's Assets Average peaked at $225.0 million during Q2 2021, and registered a low of $38.4 million during Q2 2025.
  • For the 5-year period, TherapeuticsMD's Assets Average averaged around $99.3 million, with its median value being $56.6 million (2023).
  • Per our database at Business Quant, TherapeuticsMD's Assets Average skyrocketed by 562.81% in 2021 and then tumbled by 6280.66% in 2023.
  • TherapeuticsMD's Assets Average (Quarter) stood at $189.5 million in 2021, then tumbled by 40.82% to $112.2 million in 2022, then plummeted by 58.19% to $46.9 million in 2023, then fell by 16.45% to $39.2 million in 2024, then dropped by 1.53% to $38.6 million in 2025.
  • Its Assets Average stands at $38.6 million for Q3 2025, versus $38.4 million for Q2 2025 and $38.5 million for Q1 2025.